Home > Insider Trading > Filing (0001225208-25-005681)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1533022	F Michael Mahoney	300 Boston Scientific Way Marlborough MA 01752-1234	Chairman, President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-06-02	56,212	$17.26	1,591,918	No	4	M	Direct
Common Stock	Acquisiton	2025-06-02	49,407	$24.55	1,641,325	No	4	M	Direct
Common Stock	Disposition	2025-06-02	74,522	$104.05	1,566,803	No	4	S	Direct
Common Stock	Disposition	2025-06-02	89,921	$103.39	1,476,882	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2025-06-02	56,212	$0.00	56,212	$17.26
Common Stock	Stock Option (Right to Buy)	Disposition	2025-06-02	49,407	$0.00	49,407	$24.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-02-22	No	4	M	Direct
148,221		2027-02-28	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	201,478	Indirect	By Trust

Footnotes

The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $103.83 to $104.755, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $102.83 to $103.825 inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.